AAAAAA
Results:
1-17
|
Results: 17
Authors:
NILSSON CL
HELLSTRAND M
EKMAN A
ERIKSSON E
Citation: Cl. Nilsson et al., THE INTRINSIC ACTIVITY OF (-)-3-PPP VIS-A-VIS PROLACTIN-SUPPRESSING DOPAMINE D-2 RECEPTORS IN TRANSFECTED GH(4)C(1) CELLS IS DEPENDENT ON WHICH SECRETAGOGUE THAT IS USED TO PROVOKE PROLACTIN-RELEASE, Neuropharmacology, 37(2), 1998, pp. 233-242
Authors:
EKMAN A
NISSBRANDT H
HEILIG M
DIJKSTRA D
ERIKSSON E
Citation: A. Ekman et al., CENTRAL ADMINISTRATION OF DOPAMINE D3 RECEPTOR ANTISENSE TO RAT - EFFECTS ON LOCOMOTION, DOPAMINE RELEASE AND [H-3]SPIPERONE BINDING, Naunyn-Schmiedeberg's archives of pharmacology, 358(3), 1998, pp. 342-350
Authors:
NILSSON CL
HELLSTRAND M
EKMAN A
ERIKSSON E
Citation: Cl. Nilsson et al., DIRECT DOPAMINE D-2-RECEPTOR-MEDIATED MODULATION OF ARACHIDONIC-ACID RELEASE IN TRANSFECTED CHO CELLS WITHOUT THE CONCOMITANT ADMINISTRATION OF A CA2-MOBILIZING AGENT(), British Journal of Pharmacology, 124(8), 1998, pp. 1651-1658
Authors:
EKMAN A
TORNE A
STROMBERG D
Citation: A. Ekman et al., EXPLORATION OF POLYGONAL ENVIRONMENTS USING RANGE DATA, IEEE transactions on systems, man and cybernetics. Part B. Cybernetics, 27(2), 1997, pp. 250-255
Authors:
EKMAN A
MALLMIN H
PETRENMALLMIN M
LJUNGHALL S
Citation: A. Ekman et al., MEASUREMENTS WITH DXA OF THE HIP AND HEEL ULTRASOUND BUT NOT DENSITOMETRY OF THE FINGERS PREDICT A FIRST HIP FRACTURE - A COMPARISON BETWEEN 4 DIFFERENT METHODS, Journal of bone and mineral research, 12, 1997, pp. 113-113
Authors:
EKMAN A
MALLMIN H
MICHAELSSON N
LJUNGHALL S
Citation: A. Ekman et al., EXTERNAL HIP PROTECTORS TO PREVENT OSTEOPOROTIC HIP-FRACTURES, Lancet, 350(9077), 1997, pp. 563-564
Authors:
NILSSON CL
EKMAN A
HELLSTRAND M
ERIKSSON E
Citation: Cl. Nilsson et al., INVERSE AGONISM AT DOPAMINE D-2 RECEPTORS - HALOPERIDOL-INDUCED PROLACTIN-RELEASE FROM GH(4)C(1) CELLS TRANSFECTED WITH THE HUMAN D-2 RECEPTOR IS ANTAGONIZED BY R(-)-N-PROPYLNORAPOMORPHINE, RACLOPRIDE, AND PHENOXYBENZAMINE, Neuropsychopharmacology, 15(1), 1996, pp. 53-61
Authors:
EKMAN A
NISSBRANDT H
HEILIG M
ERIKSSON E
Citation: A. Ekman et al., DOPAMINE D3 RECEPTOR ANTISENSE - EFFECTS ON DOPAMINE TURNOVER AND LOCOMOTOR-ACTIVITY IN THE RAT, Nordic journal of psychiatry, 50(2), 1996, pp. 97-97
Authors:
PIETARINENRUNTTI P
RAIVIO KO
LINNAINMAA K
EKMAN A
SAKSELA M
KINNULA VL
Citation: P. Pietarinenruntti et al., DIFFERENTIAL-EFFECTS OF TUMOR-NECROSIS-FACTOR AND ASBESTOS FIBERS ON MANGANESE SUPEROXIDE-DISMUTASE INDUCTION AND OXIDANT-INDUCED CYTOTOXICITY IN HUMAN MESOTHELIAL CELLS, Cell biology and toxicology, 12(3), 1996, pp. 167-175
Authors:
NISSBRANDT H
EKMAN A
ERIKSSON E
HEILIG M
Citation: H. Nissbrandt et al., DOPAMINE D3 RECEPTOR ANTISENSE INFLUENCES DOPAMINE SYNTHESIS IN RAT-BRAIN, NeuroReport, 6(3), 1995, pp. 573-576
Authors:
KINNULA VL
RAIVIO KO
LINNAINMAA K
EKMAN A
KLOCKARS M
Citation: Vl. Kinnula et al., NEUTROPHIL AND ASBESTOS FIBER-INDUCED CYTOTOXICITY IN CULTURED HUMAN MESOTHELIAL AND BRONCHIAL EPITHELIAL-CELLS, Free radical biology & medicine, 18(3), 1995, pp. 391-399
Authors:
STJERNLOF P
ELEBRING T
NILSSON J
ANDERSSON B
LAGERKVIST S
SVENSSON K
EKMAN A
CARLSSON A
WIKSTROM H
Citation: P. Stjernlof et al., 9-TETRAHYDRO-N,N-DI-N-PROPYL-3H-BENZINDOL-8-AMINES - DERIVATIVES AS POTENT AND ORALLY-ACTIVE SEROTONIN 5-HT1A RECEPTOR AGONISTS, Journal of medicinal chemistry, 37(20), 1994, pp. 3263-3273
Authors:
HAND A
PELIN K
HALME M
EKMAN A
MATTSON M
VALLAS M
MATTSON K
LINNAINMAA K
HUSGAFVELPURSIAINEN K
Citation: A. Hand et al., INTERFERON-ALPHA AND INTERFERON-GAMMA COMBINED WITH CHEMOTHERAPY - IN-VITRO SENSITIVITY STUDIES IN NONSMALL CELL LUNG-CANCER CELL-LINES, Anti-cancer drugs, 4(3), 1993, pp. 365-368
Authors:
STJERNLOF P
ELEBRING T
ANDERSSON B
SVENSSON A
SVENSSON K
EKMAN A
CARLSSON A
WIKSTROM H
Citation: P. Stjernlof et al., 5, 6, 7 AND N-DI-N-PROPYLAMINO)-1,2,3,4-TETRAHYDRONAPHTHALENES - CENTRALLY ACTING DA AND 5-HT(1A) AGONISTS, European journal of medicinal chemistry, 28(9), 1993, pp. 693-701
Authors:
SONESSON C
BOIJE M
SVENSSON K
EKMAN A
CARLSSON A
ROMERO AG
MARTIN IJ
DUNCAN JN
KING LJ
WIKSTROM H
Citation: C. Sonesson et al., ORALLY-ACTIVE CENTRAL DOPAMINE AND SEROTONIN RECEPTOR LIGANDS - ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, AND METHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS AND THEFORMATION OF ACTIVE METABOLITES IN-VIVO, Journal of medicinal chemistry, 36(22), 1993, pp. 3409-3416
Authors:
STJERNLOF P
GULLME M
ELEBRING T
ANDERSSON B
WIKSTROM H
LAGERQUIST S
SVENSSON K
EKMAN A
CARLSSON A
SUNDELL S
Citation: P. Stjernlof et al., 6,7,8,9-TETRAHYDRO-3H-BENZ[E]INDOLE-1-CARBALOEHYDE AND 6,7,8,9-TETRAHYDRO-3H-BENZ[E]INDOLE-1-CARBALDEHYDE - A NEW CLASS OF ORALLY-ACTIVE 5-HT1A-RECEPTOR AGONISTS, Journal of medicinal chemistry, 36(15), 1993, pp. 2059-2065
Authors:
EKMAN A
ERIKSSON E
Citation: A. Ekman et E. Eriksson, A HIGH-DOSE OF EEDQ REDUCES PITUITARY DOPAMINE-D(2) RECEPTOR DENSITY AND THE PROLACTIN SUPPRESSIVE POTENCY OF AGONISTS, European journal of pharmacology, 243(3), 1993, pp. 295-299
Risultati:
1-17
|